Phosphatidylinositol 3-kinase inhibitors
US10227350B2 · kind B2 · utility
1Cited by
45References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2017 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Sep 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application provides the compounds of formula I or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein s, t, n, R1, R2, R3, R4, R5, and R6 are as described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.